The Diagnosis of Beta-lactam Hypersensitivity in Thailand

NCT01667055 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2019-10-29

No results posted yet for this study

Summary

The true prevalence of drug allergy in patients with a history of beta-lactam hypersensitivity will be determined by using commercially available standard skin test reagents and the diagnostic agents available in Thailand. We hypothesize that only minority of patients with such a history are truly allergic.

Conditions

  • Penicillin Allergy
  • Aminopenicillin Allergy
  • Beta Lactam Adverse Reaction

Sponsors & Collaborators

  • Chulalongkorn University

    lead OTHER

Principal Investigators

  • Jettanong Klaewsongkram, MD · Chulalongkorn University

Eligibility

Min Age
7 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01667055 on ClinicalTrials.gov